Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Letizia Trincavelli

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
Cardiovascular & Hematological Disorders Drug Targets|August 26, 2015
Synthesis and Antihypertensive Action of New Imidazo[1,2-a]pyridine Derivatives , non Peptidic Angiotensin II Receptor AntagonistsSonia Laneri, Cristina Di Ronza, Antonietta Bernardi, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 26, 2006
The thyroid disruptor 1,1,1-trichloro-2,2-bis(p-chlorophenyl)-ethane appears to be an uncompetitive inverse agonist for the thyrotropin receptorMario Rossi, Antonio Dimida, Maria Teresa Dell'anno, et al.
Journal of Psychiatric Research|January 25, 2006
Upregulation of A2A adenosine receptors in platelets from patients affected by bipolar disorders under treatment with typical antipsychoticsClaudia Martini, Daniela Tuscano, Maria Letizia Trincavelli, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|February 1, 2019
Long lasting inhibition of Mdm2-p53 interaction potentiates mesenchymal stem cell differentiation into osteoblastsSimona Daniele, Chiara Giacomelli, Deborah Pietrobono, et al.
European Journal of Medicinal Chemistry|October 1, 2013
Modulation of A2B adenosine receptor by 1-Benzyl-3-ketoindole derivativesSabrina Taliani, Maria Letizia Trincavelli, Barbara Cosimelli, et al.
Biochimica Et Biophysica Acta|December 24, 2013
Allosteric modulators of human A2B adenosine receptorMaria Letizia Trincavelli, Chiara Giacomelli, Simona Daniele, et al.
Bioorganic & Medicinal Chemistry|November 13, 2018
Novel fluorescent triazinobenzimidazole derivatives as probes for labelling human A<sub>1</sub> and A<sub>2B</sub> adenosine receptor subtypesElisabetta Barresi, Chiara Giacomelli, Simona Daniele, et al.
Journal of Inorganic Biochemistry|March 15, 2021
Ruthenium(II) 1,4,7-trithiacyclononane complexes of curcumin and bisdemethoxycurcumin: Synthesis, characterization, and biological activityRiccardo Pettinari, Fabio Marchetti, Alessia Tombesi, et al.
European Journal of Medicinal Chemistry|December 3, 2014
Further studies on pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective human A1 adenosine receptor antagonistsMaria Paola Giovannoni, Giovanna Ciciani, Agostino Cilibrizzi, et al.
Journal of Medicinal Chemistry|November 11, 2005
Synthesis and 3D QSAR of new pyrazolo[3,4-b]pyridines: potent and selective inhibitors of A1 adenosine receptorsFabrizio Manetti, Silvia Schenone, Francesco Bondavalli, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Cardiovascular & Hematological Disorders Drug Targets|August 26, 2015
Synthesis and Antihypertensive Action of New Imidazo[1,2-a]pyridine Derivatives , non Peptidic Angiotensin II Receptor AntagonistsSonia Laneri, Cristina Di Ronza, Antonietta Bernardi, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 26, 2006
The thyroid disruptor 1,1,1-trichloro-2,2-bis(p-chlorophenyl)-ethane appears to be an uncompetitive inverse agonist for the thyrotropin receptorMario Rossi, Antonio Dimida, Maria Teresa Dell'anno, et al.
Journal of Psychiatric Research|January 25, 2006
Upregulation of A2A adenosine receptors in platelets from patients affected by bipolar disorders under treatment with typical antipsychoticsClaudia Martini, Daniela Tuscano, Maria Letizia Trincavelli, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|February 1, 2019
Long lasting inhibition of Mdm2-p53 interaction potentiates mesenchymal stem cell differentiation into osteoblastsSimona Daniele, Chiara Giacomelli, Deborah Pietrobono, et al.
European Journal of Medicinal Chemistry|October 1, 2013
Modulation of A2B adenosine receptor by 1-Benzyl-3-ketoindole derivativesSabrina Taliani, Maria Letizia Trincavelli, Barbara Cosimelli, et al.
Biochimica Et Biophysica Acta|December 24, 2013
Allosteric modulators of human A2B adenosine receptorMaria Letizia Trincavelli, Chiara Giacomelli, Simona Daniele, et al.
Bioorganic & Medicinal Chemistry|November 13, 2018
Novel fluorescent triazinobenzimidazole derivatives as probes for labelling human A<sub>1</sub> and A<sub>2B</sub> adenosine receptor subtypesElisabetta Barresi, Chiara Giacomelli, Simona Daniele, et al.
Journal of Inorganic Biochemistry|March 15, 2021
Ruthenium(II) 1,4,7-trithiacyclononane complexes of curcumin and bisdemethoxycurcumin: Synthesis, characterization, and biological activityRiccardo Pettinari, Fabio Marchetti, Alessia Tombesi, et al.
European Journal of Medicinal Chemistry|December 3, 2014
Further studies on pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective human A1 adenosine receptor antagonistsMaria Paola Giovannoni, Giovanna Ciciani, Agostino Cilibrizzi, et al.
Journal of Medicinal Chemistry|November 11, 2005
Synthesis and 3D QSAR of new pyrazolo[3,4-b]pyridines: potent and selective inhibitors of A1 adenosine receptorsFabrizio Manetti, Silvia Schenone, Francesco Bondavalli, et al.
Pageof 9